Specializing In Small And Early-Stage Partners, Not Just Small Batches

Navigating a complex landscape, small pharmaceutical firms seek aseptic manufacturing solutions that cater to their specific needs. This is where Singota Solutions (Bloomington, Indiana CDMO) steps in, offering expertise in small batch aseptic filler technologies and specialized capabilities in injectable formulation development. With a focus on bridging the gap for…

Transitioning From Academic Research To Pharmaceutical Industry Drug Formulation And Analytical Development

Embarking on a career transition from academic research to industry demands a nuanced understanding of the diverse demands and objectives shaping each realm. At Singota Solutions (Bloomington, Indiana CDMO), we recognize the challenges and opportunities inherent in this shift, particularly in the realm of injectable formulation development. In this article,…

Specializing In Small And Early-Stage Injectables, Not Just Small Batches

Source: Singota Solutions Navigating the complex landscape of pharmaceutical development (Injectables), particularly for small and early-stage companies, demands careful consideration of manufacturing partnerships. While large CDMOs may seem like obvious choices, their focus on high-volume production often leaves smaller projects sidelined. This shift is notable in the context of the industry's…

Deliver A Technical Package That Serves On-Time Injectable Project Completion

Source: Singota Solutions By William Powers, Singota Solutions Meeting drug development timelines — in particular, filling the first Phase 1 batch for an injectable’s clinical trial – is critical. Producing that initial batch requires the CDMO to gather information from a pharmaceutical client about its drug substance, drug product, and analytical…

Analysis Paralysis: Navigating Early-Phase Analytical Validation

Source: Singota Solutions By Dustin Lafferty, Singota Solutions Significant confusion persists across the pharmaceutical/biopharmaceutical industry relevant to early-phase analytical development and validation. While several guidance documents serve as a de facto standard, distinguishing method validation requirements from suggestions, when and how to apply those guidelines often is not a straightforward task.…

Posts pagination